VivoSim Labs Ownership | Who Owns VivoSim Labs?


OverviewChart

VivoSim Labs Ownership Summary


VivoSim Labs is owned by 4.15% institutional investors, 1.00% insiders, and 94.85% retail investors. Geode capital management is the largest institutional shareholder, holding 2.52% of VIVS shares.

VIVS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVivoSim Labs4.15%1.00%94.85%
SectorHealthcare Stocks 232.80%10.63%-143.43%
IndustryBiotech Stocks 379.48%10.37%-289.85%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Geode capital management36.85K2.52%$52.70K
Vanguard group22.37K1.53%$40.50K
Goldman sachs group16.07K1.10%$22.98K
Blackrock funding, inc. /de11.82K0.81%$16.90K
Two sigma securities18.21K0.73%$53.19K
Vanguard fiduciary trust7.00K0.48%$10.01K
Citigroup6.50K0.44%$9.30K
Tower research capital llc (trc)2.31K0.16%$3.30K
Ubs group952.000.07%$1.36K
Sbi securities221.000.02%$316.00

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Two sigma securities18.21K0.01%$53.19K
Tower research capital llc (trc)2.31K0.00%$3.30K
Geode capital management36.85K-$52.70K
Drw securities---
Golden state wealth management2.00-$3.00
Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main16.00-$46.00
Sound income strategies---
Rockefeller capital management2.00-$3.00
Ifp advisors---
Prescott group capital management---

Top Buyers

HolderShares% AssetsChange
Two sigma securities18.21K0.01%18.21K
Geode capital management36.85K-16.20K
Goldman sachs group16.07K-16.07K
Vanguard fiduciary trust7.00K-7.00K
Citigroup6.50K-1.63K

Top Sellers

HolderShares% AssetsChange
Drw securities---67.48K
Hrt financial lp---31.60K
Prescott group capital management---23.38K
Citadel advisors---19.45K
Two sigma investments, lp---11.83K

New Positions

HolderShares% AssetsChangeValue
Two sigma securities18.21K0.01%18.21K$53.19K
Goldman sachs group16.07K-16.07K$22.98K
Vanguard fiduciary trust7.00K-7.00K$10.01K
Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main16.00-16.00$46.00
Caitong asset management3.00-3.00$4.00

Sold Out

HolderChange
Cibc private wealth group-1.00
Koesten, hirschmann & crabtree-2.00
Mcilrath & eck-2.00
Cullen/frost bankers-2.00
Signaturefd-2.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202519-34.48%60,739-72.49%45.34%5-72.22%2-33.33%
Sep 30, 20252722.73%220,551210.54%837.41%1754.55%350.00%
Jun 30, 20252110.53%126,71698.99%845.74%10-47.37%2-
Mar 31, 202519-63,680-4-19---

Recent Insider Transactions


DateNameRoleActivityValue
Nov 17, 2025Gobel David-Buy$7.30K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4-1
2025 Q3--

VIVS Ownership FAQ


Who Owns VivoSim Labs?

VivoSim Labs shareholders are primarily institutional investors at 4.15%, followed by 1.00% insiders and 94.85% retail investors. The average institutional ownership in VivoSim Labs's industry, Biotech Stocks , is 379.48%, which VivoSim Labs falls below.

Who owns the most shares of VivoSim Labs?

VivoSim Labs’s largest shareholders are Geode capital management (36.85K shares, 2.52%), Vanguard group (22.37K shares, 1.53%), and Goldman sachs group (16.07K shares, 1.10%). Together, they hold 5.14% of VivoSim Labs’s total shares outstanding.

Does Blackrock own VivoSim Labs?

BlackRock is not among the top 10 institutional shareholders of VivoSim Labs.

Who is VivoSim Labs’s biggest shareholder by percentage of total assets invested?

Two sigma securities is VivoSim Labs’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 18.21K VivoSim Labs shares, valued at 53.18K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools